4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-16-159635
President and General Counsel sold 26,335 shares at an average $20.48 ($539,258)
- President and General Counsel acquired 26,335 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2016-11-25 | Option exercise | +2,043 | $10.93 | $22,330 | 205,004 | D |
| Shandell Jason B. President and General Counsel | 2016-11-25 | Sale | −2,043 | $20.59 | $42,057 | 202,961 | D |
| Shandell Jason B. President and General Counsel | 2016-11-28 | Option exercise | +24,292 | $10.93 | $265,512 | 227,253 | D |
| Shandell Jason B. President and General Counsel | 2016-11-28 | Sale | −24,292 | $20.47 | $497,201 | 202,961 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2016-11-25 | Option exercise · Employee Stock Option (right to buy) | −2,043 | 92,949 | D | ||
| Shandell Jason B. President and General Counsel | 2016-11-28 | Option exercise · Employee Stock Option (right to buy) | −24,292 | 68,657 | D | ||
| Open-market sales · 26,335 sh · avg $20.48 · $539,258 | |||||||
Loading xslF345X03/a4.xml…